Polpharma European CDMO Partner & API Manufacturer since 1951 Polpharma European CDMO Partner & API Manufacturer since 1951

X

Find US Patent Information with US Patent Number, Application Number and Patent Expiration Date of Famotidine on PharmaCompass.com

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

EU WC

EU WC

Listed Suppliers

Listed Suppliers

API REF. PRICE (USD / KG)
101
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES
left grey arrow
right gray arrow
  • TABLET;ORAL - 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • TABLET;ORAL - 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
  • FOR SUSPENSION;ORAL - 40MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Flag Ireland
Digital Content Digital Content
URL Supplier Web Content
8449910
Y
2026-07-18
22519
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Ireland
Digital Content Digital Content
URL Supplier Web Content
8309127
Y
2026-07-18
22519
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Ireland
Digital Content Digital Content
URL Supplier Web Content
8318202
Y
2026-07-18
22519
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Ireland
Digital Content Digital Content
URL Supplier Web Content
8501228
2026-07-18
U-1196
22519
RELIEF OF SIGNS AND SYMPTOMS OF RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS AND TO DECREASE RISK OF DEVELOPING UPPER GASTROINTESTINAL ULCERS IN PATIENTS W
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Ireland
Digital Content Digital Content
URL Supplier Web Content
8067451
Y
2026-07-18
U-1196
22519
RELIEF OF SIGNS AND SYMPTOMS OF RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS AND TO DECREASE RISK OF DEVELOPING UPPER GASTROINTESTINAL ULCERS IN PATIENTS W
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]